
























Helicobacter pylori, a causative agent of vitamin B12 deficiency  
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Background: Helicobacter pylori is one of the most common causes of peptic ulcer disease worldwide and a major cause of chronic 
superficial gastritis leading to atrophy of gastric glands.  
Methodology: A total of 60 patients suffering from gastric disease due to H. pylori infection were evaluated. Endoscopy was performed and 
gastric biopsies were obtained for histopathology and urease test. Blood was simultaneously collected for the determination of the levels of 
vitamin B12 and the MCV. Vitamin B12 levels were determined by chemiluminescent assay. 
Results: Our results indicate that the mean vitamin B12 level + SEM for the total population, the H.pylori infected and non-infected patients 
were 264.5+22.9, 207.7+21.9 and 419.7+39.8 respectively. H. pylori was found in 71.7% (43/60) of the patients tested. The level of vitamin 
B12 was lower than 200pg/ml (deficient) in 67.4% (29/43) of patients tested positive for H. pylori.  
Conclusion: H. pylori appears to be implicated in causing vitamin B12 deficiency. 
 
Key Words: Helicobacter pylori, Vitamin B12, Gastritis, Urease, MCV 
 
J Infect Developing Countries 2008; 2(5):346-349. 
  
Received 12 March 2008 - Accepted 10 June 2008 
 
Copyright © 2008 Sarari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
 
Introduction 
Helicobacter pylori is a fastidious gram negative 
microorganism with a spiral/helical shape and 5 to 7 
sheathed uni-polar flagella. It requires high humidity, a 
microaerophilic environment, and an incubation 
temperature of 37
o
C for growth. Although H. pylori 
colonies may appear after 3 to 5 days, the primary 
growth may take up to 7 days to appear and the colony 
morphology is described as translucent, small pinpoint 
colonies [1]. H. pylori is considered to be the most 
common human pathogen colonizing the human gastric 
mucosa [1]. The prevalence of H. pylori in the 
developed countries is 25% to 40% and is almost 100% 
in developing countries [2].  
Studies have shown that H. pylori IgG antibodies 
increase with age. It is present in 40% of those aged 1 to 
14 years, and has been reported in up to 60% of 18- to 
24-year-old Mexicans and in 100% of 60 to 69-year-
olds in Turkey [3]. H. pylori causes chronic gastritis [4] 
and peptic ulcer disease [5] and it has been classified as
 
a type I (definite) carcinogen since 1994.  This 
organism has also been implicated in increasing the risk 
of developing gastric cancer, which is the second most 
frequent cause of cancer-related
 
death [3,6].  
Furthermore, H. pylori infection has also been 
associated with an increased risk of B-cell lymphoma of 
gastric mucosa-associated-lymphoid-tissue (MALT –
lymphoma) [7,8]. 
Vitamin B12, which is a water soluble vitamin, is a 
complex molecule that cannot be synthesized in the 
human body and must be supplied in a diet containing 
meat and dairy products. Upon digestion, B12 is 
released from food and complexes with gastric intrinsic 
factor (IF).  The B12-IF complex binds to specific 
receptors in the ileum where it is absorbed. It has 
important functions in DNA replication, in the synthesis 
of red blood, and in maintaining the myelin sheath that 
surrounds nerve cells. Vitamin B12 deficiency causes 
pernicious anemia due to lack of production of intrinsic 
factor by epithelial cells in the stomach. Although many 
factors can contribute to the development of Vitamin 
B12 deficiency, pernicious anemia is mostly attributable 
to conditions associated with chronic atrophic gastritis 
[9].   
H. pylori has been suggested as an important agent 
in the aetiology of vitamin B12 deficiency and 
pernicious anemia [10]. A result of H. pylori-induced 
gastritis and ulcers is destruction of the parietal cells 
which are important for the production of intrinsic 
factor which is essential for vitamin B12 absorption.  H. 
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pylori were isolated in 56% of patients with pernicious 
anemia and eradication of the infection has been shown 
to result in improved blood levels of vitamin B12 in 40% 
patients [11]. However, H. pylori-induced vitamin B12 
deficiency has been shown to occur in the absence of 
atrophic gastric mucosa [12]. Thus the aim of this study 
was to further investigate the possible association 
between H. pylori infection and vitamin B12 deficiency. 
 
Materials and Methods 
This cross-sectional study was conducted between 
November 2003 and November 2004 The inclusion 
criteria was limited to patients diagnosed with gastritis 
by endoscopy and not taking any vitamin B12 
supplements. Patients were excluded from the study if 
they had any underlying medical condition which may 
have caused vitamin B12 deficiency, if they had 
previous administration of H. pylori eradication 
therapy,  or if they had renal failure or liver disease. 
Pregnant women were also excluded. 
For each patient enrolled, information about age, 
sex, smoking and symptoms suffered was recorded. 
Blood was collected aseptically in EDTA and plain 
vacutainer tubes for laboratory investigations. Complete 
Blood Count (CBC) was performed using Sysmex 
Analyzer (Sysmex, Japan) to determine the MCV.  
Vitamin B12 levels was determined by a competitive 
chemiluminescent immunoassay using an IMMULITE 
automated analyzer (DPC, CA, USA).   
Gastric biopsies from the antrum and duodenal 
biopsies were obtained during endoscopy. The rapid 
urease which is a qualitative test for the detection of the 
urease enzyme produced by H. pylori was conducted 
using the CLO-test (Biomer’ieux, France). H. pylori 
hydrolyzes the urea rapidly and the color change of the 
indicator within 20 minutes to one hour was indicative 
of a positive test.  If negative after one hour, the test 
was read again after 24 hours.  
Poly Stat Helicobacter pylori test kit (Polymedco 
Inc. USA) was used for the qualitative detection of anti-
Helicobacter pylori IgG in the human serum. 
Histopathology was performed on formalin fixed 
paraffin embedded biopsies.  Sections were cut at 5 
microns thick and stained with eosin and methylene 
blue. The sections were then evaluated for the presence 
of H. pylori by a pathologist.  
Statistical analysis was conducted using SPSS 
version 12 (SPSS inc., Chicago).  The presence of 
association between the different parameters was 
assessed by by Chi-Square and correlation coefficients 




Sixty patients (29 females and 31 males) who 
fulfilled the inclusion and exclusion criteria were 
enrolled in the study. H. pylori was detected in 97.7% 
(42/43) of the patients diagnosed with gastritis.  
Histopathology was used to demonstrate the presence of 
the characteristic curved or S-shaped H. pylori and to 
provide information about the nature of the patient’s 
gastritis. CLO test and serology revealed an infection 
rate of H. pylori in 71.7% (43/60) of the study 
population. Among those positive for H. pylori, the rate 
of infection was higher in males, 55.8% (24/43) versus 
44.2% (19/43) in females. The age range of the patients 
was between 18 and 82 years (mean 43.4 +17.3 years). 
With respect to age, the population was divided into 
three groups: group I (18 – 39 years), group II (40-59 
years) and group III (> 60 years). Our results indicated 
that H.  pylori was present in 56.7% of group I and 
21.7% in groups II and III (Table 1). With respect to 
smoking, 30.2% (11/43) of the H. pylori positive 
patients were smokers. 
 
Table 1. General characteristics of the parameters monitored. 
Characteristics Frequency Percentage 
Age   
18-39 (%) 34 56.7 
40-59 (%) 13 21.7 
60+ (%) 13 21.7 
Gender   
Males (%) 24 55.8 
Females (%) 19 44.2 
Smoking    
Smokers 13 30.2 
Non-smokers 30 69.8 
MCV    
Elevated (90+) 29 67.4 
Normal (<90) 14 32.6 
Vitamin B12    
Deficient (<250) 29 67.4 
Normal (>=250) 14 32.6 
H. pylori Pathology   
Present 43 71.7 
Not present  17 28.3 
CLO Test and Serology   
Positive 43 71.7 
Negative 17 28.3 
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The lower limit of normal serum vitamin B12 level 
is set at 200 pg/ml [13] and the reference level used at 
the Mayo Clinic is 200 to 650 pg/ml [14]. The mean 
vitamin B12 level (+ SEM) was 264.5 + 22.9 pg/ml in 
the total patient population (n=56). Four values were 
excluded from the mean because the levels were 
extremely elevated (1088, 1103, 1185, 1200).   The cut-
off level to determine vitamin B12 deficiency was taken 
as <200 pg/ml,   and based on this measure, 67.4% 
(29/43) of the H. pylori infected patients had Vitamin 
B12 deficiency. The mean vitamin B12 level (+ SEM) for 
the H. pylori infected patients was 207.7+21.9 as 
compared to 419.7+39.8 for the H. pylori negative 
patients. There was significant difference by the 
independent t-test (p= 0.00) between the  means of 
vitamin B12 levels of H. pylori negative and H. pylori 
positive patients  at 0.05 level of significance.  MCV 
was elevated (>90 fl) in 67.4% of the H pylori infected 
patients (29/43) (Table 2). There was significant 
association (p<0.05) between presence of H. pylori 
infection and vitamin B12 deficiency.   
 
Table 2. Association of vitamin B12 and MCV in H. pylori 
infected cases. 
 Vitamin  B12 
 Deficient (<200 pg/ml) 
MCV Number Percent 
Elevated (>90 fl) 29 67.4 
Not elevated (<90 fl) 3 7.0 
 Not deficient (>200 pg/ml) 
MCV Number Percent 
Elevated (>90 fl) 1 2.3 
Not elevated (<90 fl) 10 23.3 
Total number of cases positive for H. pylori = 43 
Coefficient of correlation between MCV and Vitamin B12 = - 0.678. 
 
Discussion 
H. pylori has been found to colonize the stomach of 
humans worldwide.  H. pylori causes the majority of 
cases of both gastritis and duodenal ulcers. The 
prevalence of H. pylori varies depending on age, race, 
ethnicity, geographical location, crowding and 
socioeconomic class. Our results indicated that age, 
gender and smoking are not significant in causing 
infections with H. pylori. 
Pernicious anemia is a type of megalobastic anemia 
due to Vitamin B12 deficiency. In order to establish an 
association between H. pylori infection and vitamin B12 
deficiency, we have chosen patients symptomatic for H. 
pylori infection. Our results showed that 71.7 % of the 
patients with gastritis were infected with H. pylori, and 
67.4% of these patients had pernicious anemia as seen 
in the elevated MCV levels. In this study, selection of 
patients was restricted to those who had no inherent 
problems related to vitamin B12 absorption or 
malnutrition. H. pylori and related gastric pathology 
emerges as a major factor responsible for vitamin B12 
deficiency.  Several studies on the relationship between 
H. pylori, gastritis and vitamin B12 deficiency have been 
conducted [9,11]. Our results agree with the results 
obtained by these studies. The main variables in this 
study were H. pylori infection and vitamin B12 
deficiency. Our results indicated a significant 
association between the two (P<0.05).  In conclusion, 
the presence of H.pylori in the gastric mucosa can be 
considered as an important factor in causing vitamin B12 
deficiency. In developing countries, where there is a 
high prevalence of H. pylori infections, one expects to 
also find vitamin B12 deficiency in certain members of 
the population. Therefore, diagnostic evaluation of 
vitamin B12 deficiency must include tests for H. pylori. 
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